{"id":120988,"date":"2021-03-29T11:12:36","date_gmt":"2021-03-29T18:12:36","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/03\/fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-multiple-myeloma"},"modified":"2021-03-29T11:12:36","modified_gmt":"2021-03-29T18:12:36","slug":"fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/03\/fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-multiple-myeloma","title":{"rendered":"FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-multiple-myeloma2.jpg\"><\/a><\/p>\n<p>Treatment for Myeloma cancer.<\/p>\n<hr>\n<p>The FDA approved Abecma, the first cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Treatment for Myeloma cancer. The FDA approved Abecma, the first cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy.<\/p>\n","protected":false},"author":621,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-120988","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/120988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/621"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=120988"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/120988\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=120988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=120988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=120988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}